There is increasing evidence that autoimmune phenomena, including auto-antibody production, may affect fertility in women with endometriosis. The aims ofthis study are to evaluate anti-laminin-l antibody (aLN-l) presence in sera and in follicular fluids (FF) of women with endometriosis undergoing IVF and its impact on oocyte maturation and IVF outcome. aLN-l were measured by a home-made enzyme linked immunosorbent assay in sera and FF obtained from 35 infertile women with endometriosis and in sera from 50 fertile controls and 27 infertile women without endometriosis (IWWE). aLN-l serum levels were significantly higher in women with endometriosis in comparison with both fertile controls and IWWE (P<O.OOI and P <0.05, respectively) and a positive correlation was found between serumand FF-aLN-l (r = 0.47, P = 0.004). According to the cut-off (mean+3 SD of fertile controls), 31% of women with endometriosis were aLN-l positive. Metaphase II oocyte counts showed inverse correlation with FF-aLN-l levels (r = -0.549, P = 0.0006). Ongoing pregnancy (i.e pregnancy progressing beyond the 12 th week of gestation) occurred in 4/11 aLN-l positive patients and in 7/24 aLN-l negative with no significant difference (P= 0.7). In conclusion, our results highlight that aLN-l are increased in women with endometriosis and their presence in FF may affect oocyte maturation leading to a reduced fertility. However, aLN-l seem to have no effect on IVF outcome.
Laminin-l (LN-l), the first identified and sequenced laminin, is a 900 kD multifunctional glycoprotein of basement membranes thought to enhance trophoblast adhesion in the peri-implantation period (1) . Laminins and their specific integrins are important components of the extracelluar matrix (ECM), due to their role in cell adhesion processes and, in particular, LN-1 is involved in embryogenesis, implantation, and placentation (2) (3) .
The effects of anti-laminin antibodies (aLN-l) on conception and pregnancy outcome has been investigated in various animal models. In monkeys, aLN-l antibodies were associated with reproductive failure (4) . In mice, passive immunization with rabbit aLN-l administered intraarnniotically in pregnant animals, resulted in a higher abortion incidence, and/or fetal death (5) , while active immunization with LN-l induced high fetal resorption rate, and low fetal and placental weights (6) .
In humans, aLN-l were initially reported as auto-antibodies (auto-Abs) associated with recurrent miscarriages. In fact, Inagaki et al. (7) documented higher IgG aLN-11evels in patients with history of2-11 first-trimester miscarriages when compared with both healthy pregnant and non-pregnant women.
Endometriosis is a disease associated with reproductive failure and cellular and humoral immune abnormalities, including autoantibody production, which could play a detrimental role impairing fertility (8) . Among the various auto-Abs described (9) (10) , recently aLN-1 have gained more attention due to their significantly higher prevalence in patients with endometriosis when compared with infertile patients without endometriosis (11) . It has been suggested that aLN-1 affect early reproductive processes, leading to autoimmune-mediated infertility (12) (13) .
In the current literature, data concerning the presence and pathogenic relevance of aLN-1 in follicular fluid (FF) are lacking and the relationship between aLN-1 and pregnancy outcome in patients undergoing in vitro fertilization (IVF) has not yet been investigated. In addition, although ECM components, including LN-1, promote follicle maturation to produce meiotically competent oocytes (14) , data concerning the possible effects of aLN-1 on oocyte maturation are lacking.
Therefore, the primary aims of this study are to evaluate: i) aLN-1 antibody levels in sera and in FF of patients with endometriosis undergoing IVF; ii) the relationship between serum-and/or FF-aLN-1 and oocyte maturation, iii) the impact of aLN-1 presence on ongoing pregnancy.
In a previous study dealing with the presence and clinical relevance of antiphospholipid antibody (APA) in infertile women undergoing IVF, we demonstrated significantly increasedAPAlevels after IVF treatment and we hypothesized a possible role of hyperestrogenism in rising auto-Ab production (15) . Since an interesting issue could be whether other auto-Abs are involved in this phenomenon, a further aim of this study is to analyze the effect of IVF treatment on aLN-1 levels.
MATERIALS AND METHODS

Patients
Thirty-five consecutive women affected by endometriosis (mean age 34.8±3.7 years, range [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] undergoing ovarian stimulation and IVF with or without intracytoplasmic sperm injection (lCSI) at the Centre of Reproductive Medicine of Bari, University Hospital were enrolled in the study which was approved by the Institutional Review Board of Bari University Hospital, and written informed consent was obtained from each patient. Endometriosis was diagnosed by laparoscopy and histological assessment of lesions. Eligibility criteria were: (1) first IVF attempt; (2) normal menstrual cycle (range of 26-32 days); (3) baseline FSH levels < 12 lUI ml; (4) body mass index (BMI) between 18-30 Kg/m'; (5) no oral contraceptive pills taken in the last year. Exclusion criteria were: (1) concomitant autoimmune disease; (2) treatment with corticosteroids, immune-suppressive drugs or immune-modulators.
The patients were down-regulated with GnRH agonist (a-GnRH-Decapeptyl 0.1 mg, IPSEN, Italy), starting in the mid-luteal phase of the previous cycle. Ovarian stimulation was carried out with a fixed daily dose of 225 UI of recombinant FSH (recFSH-Gonal F, Serono, Switzerland), starting from day 2 to 3 of the cycle for the first 5 days. The dose was adapted depending on the ovarian response to the treatment. A dose of 10,000 IU hCG (Profasi, Serono, Switzerland) was given intramuscularly for ovulation induction when two or more follicles~18 mm in diameter were present and E 2 concentrations dropped to 150-200 pg/ml for each leading follicle.
Oocyte retrieval was carried out 35-36 h later by ultrasound-guided transvaginal puncture. Oocyte nuclear maturity was assessed by evaluating the polar body extrusion immediately before ICSI or on the day after oocyte retrieval in the IVF procedure.
Fourteen days after embryo-transfer, quantitative definition of serum phCG was carried out. Clinical pregnancy was defined as fetal cardiac activity on transvaginal sonography. Pregnancy progressing beyond the 12 th week of gestation was considered to be ongoing.
Sera andfollicolarfluids
Patient sera were harvested on three different days: (i) between day 19 and 21 ofthe menstrual cycle, before starting triptorelin treatment (time 0; TO); (ii) on the day of oocyte retrieval (time 1, Tl); (iii) 14 days after ET (time 2, T2), on the day of phCG testing.
Oocyte retrieval was carried out by an Ovum Aspiration Needle Double Lumen (Cook Medical, Australia PTY LTD) and only the first aspirated FF was utilized for aLN-l detection. Samples contaminated by blood cells were excluded. After centrifugation at 2000 x g, FFs were stored at -80°C until assay.
Sera were also. obtained in the luteal phase of the menstrual cycle by two different control groups, i.e. 50 fertile women (fertile controls, FCTRs) and 27 infertile women without endometriosis (lWWE, 9 male factor, 13 tubal factor, and 5 polycystic ovary syndrome), matched for age, basal FSH, and BML They were included in the study according to the following criteria: (1) no oral contraceptive pill taken in the last year; (2) absence of autoimmune disease and/or treatments affecting immune response; (3) last pregnancy> 2 years before study entry in fertile women; (4) no previous IVF in IWWE.
Reagents
Laminin from Engelbreth-Holm-Swarm munne sarcoma basement membrane, affinity purified antilaminin antibodies produced in rabbit, bovine serum albumin (BSA), o-phenylenediamine (OPD), Tween-20, and 30% H 202 , were purchased from Sigma-Aldrich, Milan, Italy. Peroxidase (HRP)-conjugated affinity purified goat antibodies to human IgO and to rabbit IgO were obtained from Jackson Immunoresearch ,Avondale, PA, USA.
Enzyme linked immunosorbent assay (ELISA) for aLN-J determination.
In the ELISA described in this study, phosphate buffered saline (PBS) containing 0.05% (v/v) Tween-20, PBS/3% (w/v) BSA, and PBS/l % BSA/O.05/Tween 20 were used as washing, blocking, and diluent buffer, respectively. Each step, except the coating of the plates, was performed at 25°C.
Half of the wells (alternate rows) of 96-well ELISA plates (Falcon ProBind, Becton Dickinson, Oxnard, CA, USA) were coated with 500ng/l 00 ilL/well of laminin in 0.05 M carbonate/bicarbonate buffer, pH 9.6 (coating buffer), whilst the other half with 100 ul. of coating buffer alone and left overnight at 4°C. The wells were washed 4 times (250 ilL/well of washing buffer) and non-specific site on the plates were blocked by incubation for 2 h with 150 ul, of blocking buffer. After washes, 100 1lL/ well of serum or FF specimens (diluted 1:100 and 1:20, respectively) were added in duplicate in antigen coated wells as well as in non-coated wells, the latter to assess non-specific binding. Sera from the same patient at TO, T'l, and T2 were assessed on the same day and plate to minimize inter-assay variation. In each plate, rabbit anti-LN-l antibody was incubated in 2 wells at 100 ng/mL concentration to confirm antigen binding and as positive control. The assay blank value was obtained by using 100 ilL/well of diluent buffer in place of serum. After a 30 minute incubation, plates were washed 4 times and 100 ilL/well of (HRP)-conjugated anti human IgO or anti-rabbit IgO, diluted 1:8,000 were applied for 30 mins. After washings, 100 ilL/well of freshly prepared solution of OPD (0.4 mg/mL) and Hydrogen peroxide 30% (0.4 llL/mL) in citrate buffer (pH 5) were dispensed. The color reaction was stopped by addition of 50 ilL/well of 2 M H 2S04 after a 10 min incubation in the dark. Optical densities (OD) were measured at 492 nm using an ELISA reader (Bio-Rad, Hercules, CA, USA).
The mean OD of the sample duplicates in the absence of antigen was subtracted from the mean OD achieved in the presence of antigen to obtain the net OD reading. aLN-l values were expressed as percent of the positive control. Intra-and inter-assay coefficients of variation were always < 10%.
Statistical analysis
Statistical analysis was performed with version 4 of OraphPad prism software (OraphPad, San Diego, CA, USA). The results are reported as median and 25 th_75 th percentiles, numbers are presented as counts (percentage) for dichotomous data. Analyses were performed using the Mann-Whitney U test for unpaired two group analyses, Kruskal-Wallis ANOVA test for unpaired three group analyses (Dunn's post hoc test), Friedman ANOVA for paired three group analyses (Dunn's post hoc test).
Spearman rank correlation coefficient analysis was used to examine the correlation between serum and FF aL-l and between aL-l levels and oocyte count. Frequency data were compared with Fisher's exact test. P-values <0.05 were taken as statistically significant.
RESULTS
aLN-1 levels detected at TO in sera of patients with endometriosis (median 22.3% of the positive control; 25-75 th percentiles 14.9-35.5) were significantly higher in comparison with those found in both FCTRs (12; 8.9-15.7; P<O.OOl) and in IWWE (15; 9.4-22.6; P<0.05). The difference between FCTRs and IWWE was not significant (Fig. 1) .
Since aLN-l levels were normally distributed in FCTRs, cut-off was set at mean+3 SD of values obtained in FCTRs, i.e. 30.7. According to the cutoff, 11/35 (31.4%) patients with endometriosis, 1/50 (2%) of FCTRs and 2/27 (7.4%) of IWWE were aLN-l positive. aLN-1 prevalence found in patients with endometriosis was significantly higher in comparison with that found in both FC!Rs (P= 0.0002) and IWWE (P = 0.028) whereas the differences between FCTRs and IWWE was not significant.
aLN-llevels detected at T2 (median 30.1; 25-75 th percentiles 19.6-55) were significantly higher when compared with those found at TO (22. ...
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No significant correlation was found between E 2 levels evaluated at the heG day administration and serum aLN-l detected at T2 (r = 0.29, P = 0.09, data not shown).
In each woman with endometriosis, aLN-l were also measured in FFs obtained from at least two different follicles and data reported represent the mean value for a single patient. The coefficient of variation among FF-aLN-l in the same patient was always <15%.
FF-aLN-l showed significant positive correlation with serum aLN-l detected at T1, i.e the day when FFs were obtained (r = 0.47, P = 0.004) ( Fig. 3) . Also serum aLN-l found at TO and T2 significantly correlated with FF-aLN-l (r = 0.35, P = 0.04, and r = 0.41, P = 0.014, respectively).
Metaphase II (MIl) oocytes ranged from 1 to 12 (median 4) and a highly significant negative correlation was found between MIl oocyte counts and FF-aLN-l levels (r = -0.549, P = 0.0006) ( Fig.   4 A) , whereas total oocyte counts did not correlate with FF-aLN-1 levels (r = -0.15, P = 0.387) ( Fig. 4 B).
Ongoing pregnancy occurred in 4/11 aLN-l positive patients (36%) and in 7/24 aLN-1 negative (29%) being the difference not significant (P= 0.7, statistical power 70%). There was no significant difference between FF-aLN-1 levels detected in women with (median 48.4 %; 25-75 th percentiles 29.7-86.3) or without (62.5%; 48.15-79.7) ongoing pregnancy (P = 0.42, statistical power 55%). Moreover, MIl oocyte counts did not differ significantly 'between women with (median 4; 25-75 th percentiles 2-5) or without (4; 3-5) ongoing pregnancy.
DISCUSSION
Endometriosis, a disease characterized by ex1rauterine endometrial tissue development, is frequently associated with infertility likely caused by multifactorial mechanisms, including alterations of immune function, such as dysfunction ofNK activity, enhanced production ofpro-inflammatory cytokines, and polyclonal B cell activation (8, (16) (17) (18) . Several auto-Abs, i.e. antibodies against endometrium, ovary, theca cells and granulosa cells, antinuclear antibodies, antibodies to ribonucleoproteins, histones, smooth muscle, lupus anticoagulant and anticardiolipin antibodies, have been described in women with endometriosis (9, (19) (20) , and autoimmunity is thought to play an important role in reproductive failure (21) .
In this study, we show a significant increase of both aLN-l levels and aLN-1 prevalence in patients affected by endometriosis when compared with both FCTRs or IWWE, providing further evidence that disturbance in B lymphocyte functions occurs in this disease. Our results are in agreement with Inagaki et al. (11) , who demonstrated significantly higher aLN-1 levels in women with endometriosis when compared with IWWE.
LN-l plays a crucial role in the initial migration of trophoblast cells into maternal decidua during implantation and its interaction with integrin receptors regulates both proliferation and differentiation of trophoblast during implantation and placentation (22) . Therefore, it is conceivable that the inhibition of LN-1 functions exerted by aLN-l may affect very early reproductive processes, leading to infertility.
We demonstrated for the first time the presence of aLN-l in FFs of women with endometriosis. In addition, we found a positive correlation between serum-and FF-aLN-1 levels and no significant differences of aLN-1 concentrations among follicles which suggests that antibodies, like other molecules, diffuse from serum to follicular environment.
An interesting issue raised by our results is the negative correlation between MIl oocyte number and FF-aLN-I antibody levels. This finding suggests that aLN-I may exert a specific detrimental role in follicular milieu, indicating a possible relationship between FF-aLN-I presence and impaired oocyte maturation.
The in vitro effects of ECM components, including LN-I, in the regulation of ovarian follicle development, as well as on oocyte quality have been thoroughly investigated by Kreeger et al. (14) in follicles isolated from C57BL/6 female mice. To this end, immature mouse follicles were cultured within unmodified alginate matrices or, alternatively, within alginate matrices modified with specific ECM components (e.g. LN-I, fibronectin) or RGD peptides. Culture in alginate matrices modified with LN-I, fibronectin or RGD peptides resulted in a significant increase of the rate of polar body formation. Moreover, oocytes showed a more compact metaphase II spindle compared with unmodified alginate matrices, clearly indicating that LN-I play an important role in oocyte maturation.
Accordingly, it is possible that aLN-l affect LN-I functions hampering oocyte maturation, which, in turn, may result in a reduction of MIl oocyte number. This hypothesis could explain the negative correlation between MIl oocyte count and FF-aLN-l levels demonstrated in our study.
Concerning the relationship between oocyte quality and endometriosis-associated infertility, alterations within oocyte, resulting in embryos with decreased ability to implant has been suggested as a possible cause of reproductive failure (23) . In addition, a high incidence of apoptosis, along with enhanced oxidative stress of granulose cells which might affect oocyte quality has been reported (24) (25) . Finally, a significant reduction of estradiol concentrations in FF, leading to impaired oocyte maturation and oocyte quality has been described in patients with endometriosis undergoing IVF (26) .
Our data suggest that aLN-I presence in follicular environment may alter oocyte maturation, thus providing new insights into further detrimental effect of aLN-I on reproductive processes.
Since IVF plays an important role in the management of endometriosis-associated infertility, another objective of our study was to investigate the effects of aLN-I on IVF outcome. We found no relationship between serum and/or FF-aLN-I presence and IVF outcome. In fact, the rate of ongoing pregnancy was not significantly different between aLN-1 positive and aLN-1 negative patients, nor was any significant difference in FF-aLN-I levels found between women with or without ongoing pregnancy. Although these observations lack statistical power and require confirmation on a larger cohort of patients,. it could be speculated that if some oocytes reached maturation despite the presence of FF-aLN-l, fertilization and pregnancy may occur. Another possible explanation for the lack of relationship between FF-aLN-l presence and IVF failure is that the putative effect of aLN-I on implantation may be overcome by IVF procedures.
On the whole, our results indicate that, although aLN-l may reduce fertility in women with endometriosis, there is no evidence that the same auto-Abs affect IVF outcome.
On the other hand, also the impact on IVF outcome of other auto-Abs impairing fertility, such as APA, has been questioned and it is not clear whether the presence of APA is associated with implantation failure (27) .
We showed that aLN-I levels detected at T2 were significantly higher in comparison with those found at TO and Tl and this finding parallels our previous results on APA in infertile women undergoing IVF (15) .
Estrogens enhance B cell activation, protect B cells from apoptosis and may increase autoantibody production by allowing auto-reactive B lymphocytes to escape normal tolerance (28) (29) (30) . Accordingly, it is possible that hyperestrogenism induced by IVF treatment may account for aLN-I increase.
In this respect, even though we found no significant positive correlation between E z evaluated at the hCG day administration and aLN-l levels detected at T2, a tendency to significance (P = 0.09) was demonstrated. In addition, the possibility that each patient may show a different B cell response to hyperestrogenism should be taken into account. On the other hand, only a systematic monitoring of aLN-l levels over the time could elucidate whether auto-Abs increase is sustained or not and whether this phenomenon has any clinical relevance.
In conclusion, in this study we have shown for the first time that aLN-I concentrations detected in FFs inversely correlated with Mil oocyte count, suggesting that FF-aLN-I inhibit oocyte maturation.
However, IVF outcome seems not to be affected by the presence of either serum-or FF-aLN-I, suggesting that: i) IVF procedure may overcome detrimental effect(s) of aLN-l; ii) the presence of aLN-l is not predictive ofIVF failure.
